Imaging Transmembrane Kinetics: An Asymmetric Phthalocyanine Enables Fast Cellular Entry and Golgi Targeting for Enhanced Photodynamic Therapy
Journal of Biophotonics · 2026-07 · 19 (7)
DOI: 10.1002/jbio.70322 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biophotonics, online erschienen am 08.07.2026. Verfasst von Bingyang Liu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Optoelectronic Science and Technology for Medicine of Ministry of Education, Fujian Provincial Key Laboratory of Advanced Materials…. Hauptthemen laut MEDLINE: Indoles, Golgi Apparatus, Photochemotherapy, Cell Membrane. Die Arbeit nennt 42 Literaturangaben. Gefördert von: University-Industry Cooperation Project of the Fujian Provincial Science and Technology Plan, Natural Science Foundation of Fujian Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
Photodynamic therapy (PDT) is fundamentally limited by the difficulty of concurrently achieving efficient cellular uptake and precise organelle‐specific localization of photosensitizers (PSs). To address this challenge, we designed an asymmetric silicon phthalocyanine, Chol–SiPc–PIP, through axial conjugation with cholesterol and piperazine groups, aiming to optimize its cellular pharmacokinetics. Combining advanced optical microscopy techniques, we investigated the cellular behavior of Chol–SiPc–PIP at high spatiotemporal resolution. Two‐photon CLSM showed rapid uptake and Golgi accumulation in MCF‐7 cells, while FCS revealed that the piperazine moiety accelerates membrane translocation, driving fast cellular entry. Benefiting from enhanced cellular uptake kinetics, precise Golgi targeting, and favorable photophysical properties, Chol–SiPc–PIP demonstrates superior in vitro photodynamic performance, showing an IC 50 value as low as 98 nM with excellent biocompatibility. This study highlights how asymmetric molecules can be strategically engineered to control subcellular pharmacokinetics and organelle‐level photodynamic activity, offering a cell‐focused design paradigm for developing advanced PSs with translational potential.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Optoelectronic Science and Technology for Medicine of Ministry of Education, Fujian Provincial Key Laboratory of Advanced Materials Oriented Chemical Engineering, Fujian Normal University, Fuzhou, Chin…
- School of Mechanical and Electrical Engineering, Sanming University, Sanming, China.
- School of Medical Technology and Engineering, Fujian Medical University, Fuzhou, China.
Förderung
- University-Industry Cooperation Project of the Fujian Provincial Science and Technology Plan
- Natural Science Foundation of Fujian Province
- National Natural Science Foundation of China
Zitieren
APA
Liu, B., Han, Y., Chen, K., Liu, G., Chen, J., Wang, K., Peng, Y., & Yang, H. (2026). Imaging Transmembrane Kinetics: An Asymmetric Phthalocyanine Enables Fast Cellular Entry and Golgi Targeting for Enhanced Photodynamic Therapy. Journal of Biophotonics, 19(7). https://doi.org/10.1002/jbio.70322
Vancouver
Liu B, Han Y, Chen K, Liu G, Chen J, Wang K, et al. Imaging Transmembrane Kinetics: An Asymmetric Phthalocyanine Enables Fast Cellular Entry and Golgi Targeting for Enhanced Photodynamic Therapy. Journal of Biophotonics. 2026;19(7). doi:10.1002/jbio.70322
BibTeX
@article{Liu2026,
author = {Liu, Bingyang and Han, Yuanyuan and Chen, Kuizhi and Liu, Guowei and Chen, Jianling and Wang, Kun and Peng, Yiru and Yang, Hongqin},
title = {Imaging Transmembrane Kinetics: An Asymmetric Phthalocyanine Enables Fast Cellular Entry and Golgi Targeting for Enhanced Photodynamic Therapy},
journal = {Journal of Biophotonics},
year = {2026},
volume = {19},
number = {7},
doi = {10.1002/jbio.70322}
}
EUVIMED